Showing results (61-70 of 87) with videos related to

Sort By:
Pageof 9
Annals of Surgical Oncology|March 13, 2023
Delaying Surgery After Neoadjuvant Chemotherapy Affects Survival in Patients with Colorectal Peritoneal Metastases: A BIG-RENAPE Network Multicentric StudyFrédéric Dumont, Vahan Kepenekian, Valéria De Franco, et al.
The Oncologist|February 1, 2021
Radiotherapy Plus Procarbazine, Lomustine, and Vincristine Versus Radiotherapy Plus Temozolomide for IDH-Mutant Anaplastic Astrocytoma: A Retrospective Multicenter Analysis of the French POLA CohortVincent Esteyrie, Caroline Dehais, Elodie Martin, et al.
Molecular Psychiatry|June 24, 2018
New role of P2X7 receptor in an Alzheimer's disease mouse modelElodie Martin, Majid Amar, Carine Dalle, et al.
Journal of Alzheimer'S Disease : JAD|July 6, 2020
Effects of Chronic Masitinib Treatment in APPswe/PSEN1dE9 Transgenic Mice Modeling Alzheimer's DiseaseTengfei Li, Elodie Martin, Yah-Se Abada, et al.
Molecular and Cellular Neurosciences|May 7, 2011
Cellular distribution and subcellular localization of spatacsin and spastizin, two proteins involved in hereditary spastic paraplegiaReena Prity Murmu, Elodie Martin, Agnès Rastetter, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|November 24, 2006
Lysophosphatidic acid induces endothelial cell death by modulating the redox environmentSonia Brault, Fernand Gobeil, Audrey Fortier, et al.
Magnetic Resonance in Medicine|November 26, 2021
Quality control of 3D MRSI data in glioblastoma: Can we do without the experts?Fatima Tensaouti, Franck Desmoulin, Julia Gilhodes, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 7, 2013
Ascl1/Mash1 promotes brain oligodendrogenesis during myelination and remyelinationHiroko Nakatani, Elodie Martin, Hessameh Hassani, et al.
Acta Neuropathologica|February 10, 2022
Brain region-specific susceptibility of Lewy body pathology in synucleinopathies is governed by α-synuclein conformationsLaura de Boni, Aurelia Hays Watson, Ludovica Zaccagnini, et al.
Current Oncology (Toronto, Ont.)|June 26, 2024
How to Balance Prognostic Factors in Controlled Phase II Trials: Stratified Permuted Block Randomization or Minimization? An Analysis of Clinical Trials in Digestive OncologyElodie Martin, Karine Le Malicot, Catherine Guérin-Charbonnel, et al.
Pageof 9